Pink Sheet is part of Pharma Intelligence UK Limited

This site is operated by Pharma Intelligence UK Limited, a company registered in England and Wales with company number 13787459 whose registered office is 5 Howick Place, London SW1P 1WG. The Pharma Intelligence group is owned by Caerus Topco S.à r.l. and all copyright resides with the group.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction

Whole Foods merger complaint

This article was originally published in The Tan Sheet

Executive Summary

The Federal Trade Commission issues an amended complaint Sept. 8 against Whole Foods' acquisition of Wild Oats Markets, claiming the already-completed merger is "substantially reducing or eliminating competition in the operation of premium natural and organic supermarkets" in several geographic markets. The respondent has until Sept. 26 to file a response. FTC's complaint follows a same-day scheduling conference in which an administrative law judge from the agency laid out a timeline for filings and discovery leading up to a hearing before the commission on Feb. 16, 2009. The amended complaint filing was enabled by a July decision by the U.S. Court of Appeals for the District of Columbia Circuit, which reversed a lower court's ruling against FTC's motion for a preliminary injunction against the merger (1"The Tan Sheet" Aug. 18, 2008, p. 6). Whole Foods filed a petition Aug. 26 for a rehearing before the appeals court

You may also be interested in...



Whole Foods Merger Ruling Could “Embolden” Antitrust Activity – Attorney

An appeals court's questions about a merger in a key market for dietary supplement manufacturers - the Whole Foods/Wild Oats Markets deal - may impede similar deals across all U.S. industries, an antitrust law expert says

Kenvue Breaks Ground On New Headquarters, Appoints Chief Corporate Affairs Officer

Firm hosts groundbreaking for 290,000 square-foot global headquarters it’s having built in Summit, NJ, starting with 100,000 square-foot science and innovation and expected to open in 2025.  It announced adding Russell Dyer as chief corporate affairs officer starting 13 March.

Xaira Launches With $1bn-Plus And End-To-End AI Strategy

ARCH and Foresite incubated the company and recruited Genentech R&D veteran Marc Tessier-Lavigne to keep data generation, machine learning research and drug development under one roof.

Topics

Latest Headlines
See All
UsernamePublicRestriction

Register

PS102109

Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel